Overexpression of Rad51C splice variants in colorectal tumors

Arjun Kalvala; Li Gao; Brittany Aguila; Tyler Reese; Gregory A. Otterson; Miguel A. Villalona-Calero; Wenrui Duan

doi:10.18632/oncotarget.3209

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Overexpression of Rad51C splice variants in colorectal tumors

Arjun Kalvala, Li Gao, Brittany Aguila, Tyler Reese, Gregory A. Otterson, Miguel A. Villalona-Calero _ and Wenrui Duan

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:8777-8787. https://doi.org/10.18632/oncotarget.3209

Metrics: PDF 2488 views | HTML 2583 views | ?

Abstract

Arjun Kalvala1, Li Gao1, Brittany Aguila1, Tyler Reese1, Gregory A. Otterson1,2, Miguel A. Villalona-Calero1,2,3 and Wenrui Duan1,2

1 Comprehensive Cancer Center, The Ohio State University College of Medicine and Public Health, Columbus, Ohio, U.S.A

2 Division of Medical Oncology Department of Internal Medicine, The Ohio State University College of Medicine and Public Health, Columbus, Ohio, U.S.A

3 Department of Pharmacology at The Ohio State University College of Medicine and Public Health, Columbus, Ohio, U.S.A

Correspondence:

Miguel A. Villalona-Calero, email:

Wenrui Duan, email:

Keywords: Rad51C isoform overexpression, Promoter methylation, Colorectal tumors

Received: July 29, 2014 Accepted: December 24, 2014 Published: December 30, 2014

Abstract

Functional alterations in Rad51C are the cause of the Fanconi anemia complementation group O (FANCO) gene disorder. We have identified novel splice variants of Rad51C mRNA in colorectal tumors and cells. The alternatively spliced transcript variants are formed either without exon-7 (variant 1), without exon 6 and 7 (variant 2) or without exon 7 and 8 (variant 3).

Real time PCR analysis of nine pair-matched colorectal tumors and non-tumors showed that variant 1 was overexpressed in tumors compared to matched non-tumors. Among 38 colorectal tumor RNA samples analyzed, 18 contained variant 1, 12 contained variant 2, 14 contained variant 3, and eight expressed full length Rad51C exclusively. Bisulfite DNA sequencing showed promoter methylation of Rad51C in tumor cells. 5-azacytidine treatment of LS-174T cells caused a 14 fold increase in variant 1, a 4.8 fold increase for variant 3 and 3.4 fold for variant 2 compared to 2.5 fold increase in WT.

Expression of Rad51C variants is associated with FANCD2 foci positive colorectal tumors and is associated with microsatellite stability in those tumors. Further investigation is needed to elucidate differential function of the Rad51C variants to evaluate potential effects in drug resistance and DNA repair.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3209

Publication Alerts

Research Papers:

Overexpression of Rad51C splice variants in colorectal tumors

Abstract